“duchenne-muscular-dystrophy” Archives

in
Entry Author Date Location
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More 10/05/18 National
Sarepta Touts New Data and a “Signal” With Duchenne Gene Therapy 10/03/18 Boston
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More 09/28/18 National
Europe Advisory Panel Rejects Sarepta’s Duchenne Drug Once Again 09/21/18 Boston
Working with Patients and a Fresh $80M, Fulcrum Eyes a 2019 IPO 09/05/18 Boston
Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More 08/31/18 National
Fresh Off GSK Deal, Gene Therapy Startup Orchard Bags Another $150M 08/13/18 Boston
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups   07/27/18 National
PTC Dives Into Gene Therapy with $50M Agilis Biotherapeutics Deal 07/19/18 New York
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On 06/29/18 National
Summit Therapeutics Ditches Duchenne Drug In Wake of Phase 2 Failure 06/27/18 Boston
Sarepta’s Data Are First in Rush for Duchenne Gene Therapy 06/19/18 Boston
As Sarepta Preps Data, FDA Lifts Hold on Solid’s Duchenne Gene Therapy 06/18/18 Boston
Bio Roundup: Wrapping ASCO, Dreaming IPO, Rebooting Axovant & More 06/08/18 National
Life Sci Veteran Garabedian Talks Up Biotech Accelerator in Texas 04/23/18 Texas
Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More 03/16/18 National
Solid Discloses More Problems As FDA Halts Duchenne Gene Therapy Study 03/14/18 Boston
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More 02/23/18 National
Wave, Takeda Target RNA Technology at Neuro Diseases With $230M Pact 02/20/18 Boston
After Paper Shakes Sector, Gene Therapy Leader Jim Wilson Talks Safety 01/30/18 National
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
Solid Discloses Duchenne Problems in IPO & Raises Rival’s Hackles 01/25/18 Boston
Gene Therapy 2.0: New Startups Aim to Fine-Tune Gene Delivery and Control 01/04/18 Boston
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
Ed Kaye on Sarepta’s Duchenne Quest, Rising to CEO & His New Startup 11/20/17 Boston
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
No Charm: PTC’s Duchenne Drug Rejected by FDA for Third Time 10/25/17 New York
Phrixus to Launch Clinical Trials for Duchenne Drug in Early 2018 10/16/17 Detroit Ann Arbor
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
FDA Panel Pans PTC’s Audacious Plan to Force Vote on Duchenne Drug 09/28/17 New York
Page 1 of 7 next page »